MaxCyte, Inc. (NASDAQ:MXCT) Q3 2024 Earnings Call Transcript

MaxCyte, Inc. (NASDAQ:MXCT) Q3 2024 Earnings Call Transcript November 6, 2024

MaxCyte, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-0.13.

Operator: Hello and welcome to MaxCyte Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to Scott Feinberg of Investor Relations....